Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission.

The Lancet. Haematology·2026
Same author

Should we focus on sustainable thromboprophylaxis and avoid overuse of low-molecular-weight heparins?

Research and practice in thrombosis and haemostasis·2026
Same author

Splenic radiotherapy before allogeneic transplantation for myelofibrosis.

British journal of haematology·2026
Same author

Renal Vein Thrombosis: A Narrative Review.

Diagnostics (Basel, Switzerland)·2026
Same author

DIC in pregnancy: lessons from an international registry of the International Society for Thrombosis and Hemostasis: Communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

Nephron·2026

Related Experiment Video

Updated: Sep 10, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.4K

Machine Learning in Venous Thromboembolism-Why and What Next?

Gerard Gurumurthy1, Filip Kisiel2,3, Lianna Reynolds4

  • 1The University of Manchester, Manchester, United Kingdom.

Seminars in Thrombosis and Hemostasis
|August 19, 2025
PubMed
Summary

Machine learning (ML) shows promise in predicting venous thromboembolism (VTE) and related risks, outperforming traditional scores in some areas. However, challenges like bias, transparency, and clinical integration must be addressed for widespread adoption in VTE management.

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.2K
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.1K

Related Experiment Videos

Last Updated: Sep 10, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.4K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.2K
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.1K

Area of Science:

  • Cardiovascular Medicine
  • Medical Informatics
  • Artificial Intelligence in Healthcare

Background:

  • Venous thromboembolism (VTE) is a significant cause of morbidity and mortality, complicated by numerous risk factors and challenges in balancing thromboprophylaxis with bleeding risk.
  • Current clinical risk scores for VTE have limited accuracy across diverse patient groups.
  • Machine learning (ML) offers potential solutions to improve VTE risk prediction and management.

Purpose of the Study:

  • To review the application and effectiveness of machine learning (ML) in predicting venous thromboembolism (VTE) and associated bleeding risks.
  • To identify the strengths and limitations of current ML models in VTE prediction.
  • To outline future directions for developing and implementing ML in clinical VTE care.

Main Methods:

  • Review of existing literature on ML applications in VTE prediction, including imaging analysis, surgical cohorts, cancer-associated thrombosis, and bleeding risk assessment.
  • Analysis of performance metrics (e.g., AUC) for various ML algorithms compared to traditional risk scores.
  • Identification of common challenges such as bias, external validation, transparency, and clinical workflow integration.

Main Results:

  • ML models, including convolutional neural networks and gradient-boosting models, show high performance in detecting VTE on imaging (AUCs 0.85-0.96) and predicting postoperative VTE (AUCs 0.70-0.80).
  • ML models demonstrate potential in predicting cancer-associated thrombosis (AUCs 0.68-0.82) and recurrent VTE (AUCs 0.93-0.99), though with caveats.
  • Bleeding risk prediction using ML remains challenging, often comparable to conventional models, and concerns regarding bias and external validation persist across applications.

Conclusions:

  • Machine learning demonstrates significant potential to enhance the accuracy of venous thromboembolism (VTE) risk prediction beyond traditional methods.
  • Addressing limitations such as algorithmic bias, lack of transparency, and the need for robust external validation is crucial for clinical translation.
  • Future research should prioritize standardized reporting, interpretable models, prospective validation, and seamless integration into electronic health records for effective ML deployment in VTE management.